title: Scheduling of anticancer drugs: timing may be everything.
abstract: Many cancer patients are treated with a combination of anticancer drugs. Here, we discuss the importance of drug scheduling and the need for studies that investigate the optimal timing of the various anticancer drugs. Positron emission tomography (PET) using radiolabeled anticancer drugs could be an important tool for those studies.
authors.affiliation: Department of Nuclear Medicine & PET Research, VU University Medical Center, Amsterdam, The Netherlands. aam.vanderveldt@vumc.nl
authors.forename: Astrid A M
authors.initials: AA
authors.lastname: Van der Veldt
authors.forename: Adriaan A
authors.initials: AA
authors.lastname: Lammertsma
authors.forename: Egbert F
authors.initials: EF
authors.lastname: Smit
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000737:chemistry; D004334:Drug Administration Schedule; D006801:Humans; D007553:Isotope Labeling; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000008:administration & dosage* / Q000737:chemistry
chemical_list: D000970:Antineoplastic Agents; D019275:Radiopharmaceuticals